References
- Daugaard G. Unknown primary tumours. Cancer Treat Rev 1994; 20: 119–47
- Greco FA, Hainswoth JD. Cancer of unknown primary site. Cancer: Principles and practice of oncology4th ed, TV De Vita, S Hellman, SA Rosenberg. J. B. Lippincott Co, Philadelphia 1997; 2423–2443
- Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands 1993. The Netherlands Cancer Registry, Utrecht 1993
- Cancerregistret. Cancer incidence in Sweden. 2006. www.Socialstyrelsen.se.
- Cancerregistret. Cancer incidence in Sweden. 2007. www.Socialstyrelsen.se.
- Pavlidis N. Forty years experience of treating cancer of unknown primary. Acta Oncol 2007; 46: 592–601
- Abruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Leugi R, Frost P. Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994; 12: 1272–80
- Randén M, Lewin F, Helde-Frankling M, Johansson H, Lagerros C, Rutqvist LE. Cancer with unknown primary-implementation of a regional referral process and clinical practice guidelines. Clin Oncol 2008; 20: 564
- Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26
- Falk J, Carstens H, Lundell L, Albertsson M. Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol 2007; 14: 1–5
- Brooks DR, Klint A, Dickman PW, Ståhle E, Lambe M. Temporal trends in non-small lungcancer survival in Sweden. Br J Cancer 2007; 12: 519–22
- Janssen-Heijnen MLG, Scipper RM, Klinkhamer PJJM, Crommelin MA, Mooi WJ, Coebergh JW. Divergent changes in survival for histological typer of non-small-cell lung cancer in southeastern Netherlands since 1975. Br J Cancer 1998; 77: 2053–7
- Kato I, Tominaga S, Ikarl A. Lung cancer prognostic factors from the AICHI Cancer Registry. Jpn J Clin Oncol 1990; 20: 238–45
- Lembersky BC, Thomas LC. Metastases of unknown primary site. Med Clin North Am 1996; 80: 153–71
- Shildt RA, Kennedy PS, Chen TT, et al. Management of patients with metastatic adenocarcinoma of unknown origin: A Southwest Oncology Group study. Cancer Treat Rep 1983; 67: 77–9